Corbus Pharmaceuticals Strengthens Balance Sheet with up to $121 Million in New Capital
Previous
Previous
COLORESCIENCE® ANNOUNCES SUCCESSFUL COMPLETION OF $30 MILLION DEBT FINANCING-SUPPORTING CONTINUED GROWTH IN CORE CHANNELS
Next
Next